Back
Akero Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
AKRO
Sponsored
$200 Trillion "AI Phase 2" Moments Away?
And if you click here now, you'll see how YOU could get a piece of the action...
Buy
57
AKRO
Akero Therapeutics
Last Price:
25.24
Seasonality Move:
12.31%
7 Day Trial
ALL ACCESS PASS
$
7
NEW: AI Breakthrough to Send Economy Skyrocketing by $200 Trillion?
And with the one move I detail here, you can secure a share of this 10,000% boom.Akero Therapeutics Price Quote
$25.24
+0.01 (+3.1%)
(Updated: March 29, 2024 at 6:25 AM ET)
Akero Therapeutics Key Stats
Buy
57
Akero Therapeutics (AKRO)
is a Buy
Day range:
$23.71 - $25.43
52-week range:
$11.25 - $58.38
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
3.25%
Volume:
593.2K
Avg. volume:
1.9M
1-year change:
-34.16%
Market cap:
$1.7B
Revenue:
$0
EPS:
$-2.88
How Much Does Akero Therapeutics Make?
Data Unavailable
Is Akero Therapeutics Growing As A Company?
Data Unavailable
Akero Therapeutics Stock Price Performance
-
Did Akero Therapeutics Stock Go Up Last Month?
Akero Therapeutics share price went down by -7.34% last month -
Did AKRO's Share Price Rise Over The Last Year?
AKRO share price fell by -34.16% over the past 1 year
What Is Akero Therapeutics 52-Week High & Low?
-
What Is Akero Therapeutics’s 52-Week High Share Price?
Akero Therapeutics has traded as high as $58.38 over the past 52 weeks -
What Is Akero Therapeutics’s 52-Week Low Share Price?
Akero Therapeutics has traded as low as $11.25 over the past 52 weeks
Akero Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Akero Therapeutics?
-
How Much Debt Does Akero Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Akero Therapeutics Have?
Cash and short term investments quarterly total is $550M -
What Is Akero Therapeutics’s Book Value Per Share?
Book value per share is 9.60
Is Akero Therapeutics Cash Flow Positive?
-
What Is AKRO Cash Flow From Operations?
Cash flow from operations (TTM) is -$145.4M -
What Is Akero Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $353.3M -
What Is Akero Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$223.6M
Akero Therapeutics Return On Invested Capital
Data Unavailable
Akero Therapeutics Earnings Date & Stock Price
-
What Is Akero Therapeutics's Stock Price Today?
A single share of AKRO can be purchased today for 25.23 -
What Is Akero Therapeutics’s Stock Symbol?
Akero Therapeutics trades on the nasdaq under the ticker symbol: AKRO -
When Is Akero Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Akero Therapeutics is scheduled on May 15, 2024 -
When Is AKRO's next ex-dividend date?
Akero Therapeutics's next ex-dividend date is May 26, 2020 -
How To Buy Akero Therapeutics Stock?
You can buy Akero Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Akero Therapeutics Competitors
-
Who Are Akero Therapeutics's Competitors?
Below is a list of companies who compete with Akero Therapeutics or are related in some way:
Akero Therapeutics Dividend Yield
Data Unavailable
Akero Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -19.56% |
Revenue: | 0% | 0% |
Analyst Recommendations
Buy Recommendations: | 6 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 51.25 |
Upside from Last Price: | 103.13% |